ADMA vs PAYC · P/E 22, rev $426.5M vs P/E 33, rev $1.88B
ADMA Biologics Inc (ADMA) versus Paycom Soft (PAYC) — a side-by-side from cached financials, not a winner call.
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
Paycom Soft (PAYC) is a software - application company listed on US.
Latest reported ADMA revenue for 2024-12-31 was $426.5M. Net income was $197.7M. Revenue was up 65.2% from 2023-12-31 to 2024-12-31. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
Latest reported PAYC revenue for 2024-12-31 was $1.88B. Net income was $502.0M. Revenue was up 11.2% from 2023-12-31 to 2024-12-31. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
ADMA currently screens at market cap $4.39B and trailing P/E 21.9. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
Not investment advice. Open the ADMA and PAYC stock pages for the full models.
Not investment advice.